Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards method

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 1, 1996, Pages 9-13

  Coutant, Christiane ^a   Olden, Dianne ^a   Bell, Jan ^a   Turnidge, John D ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; GOOD LABORATORY PRACTICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS SAPROPHYTICUS;

EID: 0030152186     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/0732-8893(96)00070-3     Document Type: Article

References (18)

1. Acar J, Bergogne-Bérézin E, Brogard JM, et al. (1993) Communiqué 1993 du Comité de L'antibiogrammme de Societé Francaise de Microbiologie. Pathol Biol 41:741-748.
2. Bell SM (1975) The calibrated dichotomous system (CDS) for sensitivity testing. Pathology (Suppl):1-48.
3. Brunden MN, Zurenko GE, Kapik B (1992) Modifications of the error-rate bounded classification scheme for use with two MIC break points. Diagn Microbiol Infect Dis 15:135-140.
4. Carr WD, Wall AR, Georgala-Zervogiani S, Stratigos J, Gouriotou K (1994) Fusidic acid tablets in patients with skin and soft tissue infection: a dose-finding study. Eur J Clin Res 5:87-95.
5. Godtfredsen W, Roholt K, Tybring L (1962) Fucidin. A new orally active antibiotic. Lancet i:928-931.
6. Guenthner SH, Wenzel RP (1984) In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 26:268-269.
7. Metzler CM, DeHaan RM (1974) Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis 130:588-594.
8. National Committee for Clinical Laboratory Standards (NCCLS) (1993a) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. 3rd edition. Villanova, PA: NCCLS.
9. National Committee for Clinical Laboratory Standards (NCCLS) (1993b) Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A5. 5th edition. Villanova, PA: NCCLS.
10. National Committee for Clinical Laboratory Standards (NCCLS) (1994) Development of in vitro susceptibility testing criteria and quality control parameters: approved guideline M23-A. Villanova, PA: NCCLS.
11. Pohold DJ, Saravolatz LD, Somerville MM (1987) In vitro susceptibility of gram-positive cocci to LY146032, teicoplanin, sodium fusidate, vancomycin, and rifampicin. J Antimicrob Chemother 20:197-202.
12. Swedish Reference Group for Antibiotics (1981) A revised system for antibiotic sensitivity testing. Scand J Infect Dis 13:148-152.
13. Taburet AM, Guibert J, Kitzis MD, Sorensen H, Acar JF, Singlas E (1990) Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. J Antimicrob Chemother 25 (Suppl B):23-31.
14. Toma E, Barriault D (1995) Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for Gram-positive cocci. J Clin Microbiol 33:1712-1715.
15. Verbist L (1990) The antimicrobial activity of fusidic acid. J Antimicrob Chemother 25(Suppl B):1-5.
16. Werkgroep Richtlijnen Gevoeligheidsbepalingen Report (1981) Standaardisatie van gevoeligheidsbepalingen. Bilthoven.
17. Wiedemann B, Atkinson B (1991) Susceptibility to antibiotics: species incidences and trends. In Antibiotics in Laboratory Medicine, Ed, V. Lorian. Baltimore: Williams and Wilkins.
18. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy (1991) A guide to sensitivity testing. J Antimicrob Chemother 27(Suppl D):1-50.